Crossref
Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?
Cosmoderma · 2026-07-18 · 6 · 86
DOI: 10.25259/csdm_94_2026 ↗At a glance
Journal article in Cosmoderma, published online on 2026-07-18. Written by Rachita S Dhurat and 3 co-authors. 5 references.
Abstract (original language)
Sažetak nije dostupan.
Cite
APA
Dhurat, R. S., Sharma, R., Ranka, A., & Kale, G. (2026). Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?. Cosmoderma, 6, 86. https://doi.org/10.25259/csdm_94_2026
Vancouver
Dhurat RS, Sharma R, Ranka A, Kale G. Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?. Cosmoderma. 2026;6:86. doi:10.25259/csdm_94_2026
BibTeX
@article{Dhurat2026,
author = {Dhurat, Rachita S and Sharma, Richa and Ranka, Archi and Kale, Grishma},
title = {Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?},
journal = {Cosmoderma},
year = {2026},
volume = {6},
pages = {86},
doi = {10.25259/csdm_94_2026}
}
EUVIMED